These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27027961)

  • 1. Mechanisms to Suppress ILC2-induced Airway Inflammation.
    Kabata H; Moro K; Koyasu S; Fukunaga K; Asano K; Betsuyaku T
    Ann Am Thorac Soc; 2016 Mar; 13 Suppl 1():S95. PubMed ID: 27027961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin.
    Liu S; Verma M; Michalec L; Liu W; Sripada A; Rollins D; Good J; Ito Y; Chu H; Gorska MM; Martin RJ; Alam R
    J Allergy Clin Immunol; 2018 Jan; 141(1):257-268.e6. PubMed ID: 28433687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Janus kinase-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells in asthma.
    Shimora H; Matsuda M; Nakayama Y; Maeyama H; Tanioka R; Tanaka Y; Kitatani K; Nabe T
    Immunology; 2024 Aug; 172(4):653-668. PubMed ID: 38786548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9
    Verma M; Liu S; Michalec L; Sripada A; Gorska MM; Alam R
    J Allergy Clin Immunol; 2018 Sep; 142(3):793-803.e8. PubMed ID: 29132961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
    Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
    J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
    Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
    J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
    Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
    J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma.
    Matsuyama T; Matsuyama H; Dotake Y; Takagi K; Machida K; Inoue H
    Front Immunol; 2022; 13():930862. PubMed ID: 35911708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation.
    Kabata H; Moro K; Fukunaga K; Suzuki Y; Miyata J; Masaki K; Betsuyaku T; Koyasu S; Asano K
    Nat Commun; 2013; 4():2675. PubMed ID: 24157859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR3-driven IFN-β antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung.
    Tei R; Iijima K; Matsumoto K; Kobayashi T; Lama J; Jacobsen EA; Kita H
    J Allergy Clin Immunol; 2022 Mar; 149(3):1044-1059.e5. PubMed ID: 34428519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production.
    Doherty TA; Khorram N; Lund S; Mehta AK; Croft M; Broide DH
    J Allergy Clin Immunol; 2013 Jul; 132(1):205-13. PubMed ID: 23688412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
    Thio CL; Chi PY; Lai AC; Chang YJ
    J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are ILC2s Jekyll and Hyde in airway inflammation?
    Ealey KN; Moro K; Koyasu S
    Immunol Rev; 2017 Jul; 278(1):207-218. PubMed ID: 28658554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group 2 Innate Lymphoid Cells Exhibit a Dynamic Phenotype in Allergic Airway Inflammation.
    Li BWS; Stadhouders R; de Bruijn MJW; Lukkes M; Beerens DMJM; Brem MD; KleinJan A; Bergen I; Vroman H; Kool M; van IJcken WFJ; Rao TN; Fehling HJ; Hendriks RW
    Front Immunol; 2017; 8():1684. PubMed ID: 29250067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteinyl leukotriene E
    Salimi M; Stöger L; Liu W; Go S; Pavord I; Klenerman P; Ogg G; Xue L
    J Allergy Clin Immunol; 2017 Oct; 140(4):1090-1100.e11. PubMed ID: 28115217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group 2 innate lymphoid cells and asthma.
    Kabata H; Moro K; Koyasu S; Asano K
    Allergol Int; 2015 Jul; 64(3):227-34. PubMed ID: 26117253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics.
    Malik B; Bartlett NW; Upham JW; Nichol KS; Harrington J; Wark PAB
    Respirology; 2023 Aug; 28(8):758-766. PubMed ID: 37114915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma.
    Xue L; Li C; Ge G; Zhang S; Tian L; Wang Y; Zhang H; Ma Z; Lu Z
    Front Pharmacol; 2021; 12():703724. PubMed ID: 34305612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease.
    Cavagnero K; Doherty TA
    J Cytokine Biol; 2017 Aug; 2(2):. PubMed ID: 28959799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic changes in group 2 innate lymphoid cells (ILC2s) in a steroid-insensitive asthma model of mice.
    Matsuda M; Tanaka Y; Shimora H; Takemoto N; Nomura M; Terakawa R; Hashimoto K; Sakae H; Kanda A; Iwai H; Kitatani K; Nabe T
    Eur J Pharmacol; 2022 Feb; 916():174732. PubMed ID: 34971621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.